Skretting and Proteon to trial bacteriophages for aquaculture
30 January 2021
Skretting and Proteon Pharmaceuticals are co-developing products using bacteriophages to support fish farmers as part of a holistic health strategy.
The companies will work in a parallel R&D pipeline for the project to target pathogenic bacteria. With bacterial challenges being some of the most prevalent in aquaculture worldwide, the products will be a welcome addition to the holistic health toolbox for farmers.
Further reading: The Fish Site
Author(s): The Fish Site
Healthy Animals Secure Foods
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
